companydata.dkcompanydata.dk

EVOLVA BIOTECH A/S: Financial statements 2018

CVR: 25532538

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

EVOLVA BIOTECH A/S (CVR 25532538) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,917,430 and a net result of DKK 241,386 compared with DKK -724,539 the year before. That is a decrease of 94.1% compared with the year before. Equity in the 2018 report amounted to DKK 6,762,405. The solvency ratio was 83.9%.

Gross Profit
DKK 2,917,430
Profit/Loss
DKK 241,386
Equity
DKK 6,762,405
Total Assets
DKK 8,056,915

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-2.9 mio.241 t.6.8 mio.-
201769.9 mio.49.9 mio.-725 t.6.5 mio.57
201659.9 mio.41.9 mio.-620 t.7.2 mio.56
201547.7 mio.--1.1 mio.7.9 mio.-
201439.4 mio.28.4 mio.1.8 mio.8.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

EVOLVA BIOTECH A/S: The 2017 annual report is outMay 29, 2018

EVOLVA BIOTECH A/S has published its annual report for 2017. Revenue came to DKK 69,884,999, and the net result was DKK -724,539.

About EVOLVA BIOTECH A/S

EVOLVA BIOTECH A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2000. The company has been dissolved on 17 June 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ARPIDA A/S and COMBIO A/S. The company has 2 employees (2018). In 2020, the company reported a gross profit of DKK -116,208 and a net result of DKK -196,806 compared with DKK -187,015 the year before. Equity in the 2020 report amounted to DKK 6,378,584.

Source: annual report 2020, Danish Business Authority